Suraksha Diagnostic Limited has informed the Exchange about Copy of Newspaper Publication for the unaudited (standalone and consolidated) financial results of the Company for quarter and three months ended 30 June 2025
SURAKSHA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Suraksha Diagnostic Limited has submitted to BSE and NSE scanned copies of the newspaper publication of its unaudited standalone and consolidated financial results for the quarter ended 30 June 2025, as required under SEBI Listing Regulations. The results were published on 9 August 2025 in Business Standard (English) and Aajkaal (Bengali). The Board had approved the results at its meeting held on 8 August 2025, and the statutory auditors issued a limited review report. The full results and review report are also available on the company's website (www.surakshanet.com). The filing is signed by Dr. Somnath Chatterji, Chairman & Joint Managing Director.
This is a routine regulatory compliance filing confirming that Q1 FY26 results have been published in newspapers as mandated by SEBI. It does not contain new financial information beyond the already filed results and is unlikely to have any direct impact on the stock price. Shareholders can review the detailed numbers on the company or stock exchange websites.